Prof. Cummings (Portsmouth, UK)

My experience of Trajenta® is that it consistently lowers HbA_1c, typically in the region of 0.6 percent or more and of course if you start with a higher baseline HbA_1c, you will see an even greater reduction in HbA_1c. And this is very consistent with what we see within the DPP4 class.